NCPA's qAM

qAM

Teva recalls all amlodipine/valsartan combination products

by NCPA | Nov 30, 2018

Teva Pharmaceuticals is recalling all lots of amlodipine and valsartan combination tablets and amlodipine, valsartan, and hydrochlorothiazide (HCTZ) combination tablets due to the presence of N-Nitrosodiethylamine. Teva has recalled other valsartan-containing products in recent months due to the presence of N-Nitrosodimethylamine. With this recall, Teva has now recalled all their unexpired valsartan-containing products from the U.S. market.

The Food and Drug Administration has updated the list of valsartan products under recall and the list of valsartan products not under recall. More information: FDA updates on angiotensin II receptor blocker recalls.